Blockade of cytotoxic T-lymphocyte antigen-4 as a new therapeutic approach for advanced melanoma. [electronic resource]
- Expert opinion on pharmacotherapy Dec 2011
- 2695-706 p. digital
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Review
1744-7666
10.1517/14656566.2011.629187 doi
Animals Antibodies, Monoclonal--therapeutic use Antineoplastic Agents--therapeutic use CTLA-4 Antigen--immunology Humans Immunotherapy Ipilimumab Melanoma--therapy Skin Neoplasms--therapy